Connect with us

Brilife

All the nearly 900 participants in the Phase II trial of Israel’s BriLife coronavirus vaccine candidate have been recommended to get a booster shot of @Pfizer 6 months after they were inoculated. Report by @MaayanJaffe | #Israel | #vaccine | #coronavirus (@Jerusalem_Post)

Published

on

Trending

Copyright © 2021 The COVID Site.